Vivos Inc Signs a MOU for a New Regional Clinic in NY for IsoPet Therapy
18 oct. 2021 09h30 HE
|
Vivos Inc.
Richland WA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that it signed a Memorandum of Understanding with the Animal Hospital Surgical Center in East...
Vivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™
20 sept. 2021 09h30 HE
|
Vivos Inc.
Richland WA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. is pleased to announce that it has submitted the IDE, Investigational Device Exemption for The Early Feasibility...
Vivos Inc Extends it Intellectual Property Protection
01 déc. 2020 09h30 HE
|
Vivos Inc.
Richland WA, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that it received the Patent Cooperation Treaty (PCT) International Search Report on our patent...
Vivos Inc Applies for Breakthrough Device Designation for Radiogel™
20 nov. 2020 09h30 HE
|
Vivos Inc.
Richland WA, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced that it has completed its submission to the FDA seeking Breakthrough Device Designation for Radiogel™. ...